NUGEN MEDICAL DEVICES INC (NGMD.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:NGMD • CA67054F1009

0.035 CAD

+0.01 (+16.67%)

Last: Jan 30, 2026, 07:00 PM

Fundamental Rating

Taking everything into account, NGMD scores 1 out of 10 in our fundamental rating. NGMD was compared to 0 industry peers in the Unkown industry. NGMD has a bad profitability rating. Also its financial health evaluation is rather negative. NGMD does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

NGMD had negative earnings in the past year.
In the past year NGMD has reported a negative cash flow from operations.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	-16.43%
ROE	N/A
ROIC	N/A

ROA(3y)-85.48%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

In the last couple of years the Gross Margin of NGMD has declined.
The Profit Margin and Operating Margin are not available for NGMD so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	54.96%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-8.27%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NGMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
NGMD has more shares outstanding than it did 1 year ago.
NGMD has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -3.23, we must say that NGMD is in the distress zone and has some risk of bankruptcy.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-3.23

ROIC/WACCN/A

WACC5.73%

2.3 Liquidity

A Current Ratio of 5.84 indicates that NGMD has no problem at all paying its short term obligations.
NGMD has a Quick Ratio of 5.60. This indicates that NGMD is financially healthy and has no problem in meeting its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	5.84
Quick Ratio	5.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.63% over the past year.
Looking at the last year, NGMD shows a very negative growth in Revenue. The Revenue has decreased by -22.72% in the last year.
Measured over the past years, NGMD shows a very strong growth in Revenue. The Revenue has been growing by 94.29% on average per year.

EPS 1Y (TTM)76.63%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%39.71%

Revenue 1Y (TTM)-22.72%

Revenue growth 3Y94.29%

Revenue growth 5YN/A

Sales Q2Q%-93.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.